Virax Biolabs Group Ltd (VRAX) — 20-F Filings
All 20-F filings from Virax Biolabs Group Ltd. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
Virax Biolabs Revenue Plunges 90% Amid Post-Pandemic Slump
— Jul 2, 2025 Risk: high
Virax Biolabs Group Ltd reported a significant decline in revenue for the fiscal year ended March 31, 2024, plummeting to £1,043,000 from £10,147,000 in the pri -
Virax Biolabs Files 20-F for FY Ending March 31, 2024
— Aug 20, 2024 Risk: medium
Virax Biolabs Group Ltd filed its 20-F report for the period ending March 31, 2024. The company, incorporated in E9 and headquartered in Lanarkshire, UK, operat
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX